Abstract：Objective To explore the effectiveness of Tirofiban Hydrochloride in the treatment of coronary heart disease.Methods A total of 88 patients with coronary heart disease admitted to the Iron Coal General Hospital of Liaoning Health Industry Group from June 2018 to June 2020 were selected as the research objects. They were divided into a control group (44 cases) and a test group (44 cases) by the odd and even number grouping method. The control group used conventional treatment, and the test group was treated with Tirofiban Hydrochloride on the basis of conventional treatment. The treatment efficiency, cardiac function, homocysteine (Hcy), high-sensitivity C-reactive protein (hs-CRP)levels and the rate of adverse events were compared between the two groups. Results The total effective rate of the test group was higher than that of the control group, the difference was statistically significant (P＜0.05). After treatment, the output per minute, ejection fraction and stroke volume of the test group were higher than those of the control group, the differences were statistically significant (P＜0.05). The levels of Hcy and hs-CRP in the test group were lower than those in the control group, the differences were statistically significant (P＜0.05). The total incidence rate of adverse events in the test group was lower than that in the control group, the difference was statistically significant (P＜0.05).Conclusion Tirofiban Hydrochloride in the treatment of coronary heart disease can significantly improve the clinical efficacy, improve heart function, reduce the body′s inflammatory reaction, and reduce the occurrence of adverse events.
京公网安备 11010502046607号